Tapping Asian Market with Global Vision, EuroEyes Links Up Investors by Leveraging on IR Excellence
Established in 1993 in Hamburg, Germany, EuroEyes has 26 eye surgery centers and ophthalmology clinics in Germany, Denmark and China, it is the largest ophthalmic chain diagnosis and treatment institution in Germany.
EuroEyes focuses on refractive errors (laser or intraocular lens surgery for the treatment of myopia, high myopia, hyperopia, presbyopia and cataracts). As a pioneer in ophthalmic surgery technology, the founder, chairman, executive director and CEO of the EuroEyes Clinic Group, Dr. Jørn Slot Jørgensen leads a professional medical team which has performed more than 500,000 cases of ophthalmic refractive surgery cases through the last 27 years and is nowadays considered as the world champion in the field of presbyopia treatment and European champion in the field of myopia treatment. EuroEyes is characterized by the use of surgical standards and equipment from Germany and being one of the pioneers in their field. All the surgeons performing the full range of refractive surgery at EuroEyes across Europe and China are educated in Germany and among the most renowned surgeons in the industry.
With the huge demand for refractive eye surgery that EuroEyes has met in China since they opened their first clinic in Shanghai in 2013, the group then successfully listed in Hong Kong in 2019 to support its expansion in Asia.
Building Investor Communication Through Multiple Channels
The Group is one of the leading brands in the vision correction industry that combines German ophthalmology excellence and 26 years of professional experience with bespoke customer care service. Leveraging on strong brand reputation, EuroEyes has become one of the few eye clinic groups with a far-reaching and rapidly growing geographical coverage, providing services in Germany, Denmark and the PRC.
EuroEyes has been developing its ophthalmic services in different parts of the world, the Group has spared much effort in communicating with global investors, striving to deliver accurate, credible and timely information about development strategy to investors and stakeholders. In order to facilitate a convenient and effective communicate channel, an exclusive email channel has been set up for Investor communication purpose and questions that are smoothly processed by IR team. Taking into consideration in providing company highlights for institutional investors, the Group enables interaction with investors to maintain closer communication through online and offline meetings in a regular manner. Apart from distributing information through the Company’s channels and HKEX, company information such as details of new services and new branches, strategies partnerships planning etc., are all available on the website of the Company.
Dedicated to Enhancing Corporate Governance
EuroEyes is committed to upholding the top management practices, whilst seeking to maintain the momentum of refining corporate governance in the contexts of strategic decisions, business operations, financial management, operational efficiency and information disclosure. Under the leadership of the professional ophthalmologists, EuroEyes provides the best ophthalmic services with continued effort in exploring advanced skills and materials, as well as ensuring every single detail is fully monitored and controlled. While maximizing the potential of each department, EuroEyes also actively optimizes its organizational structure to enhance efficiency so as to deliver on corporate objectives and generate greater returns for the shareholders in the future.
Outstanding Investor Relations Empowers Strategic Market Expansion
Looking forward to the coming year, the Group will continue to strengthen its position in the vision correction market with a number of business strategies, including increasing the Group’s influence and business coverage through external acquisitions, mergers and the opening of new clinics; expanding its patient base by offering new lines of services, and also adopting new technologies and equipment to provide patients with better medical services.
Euroeyes is dedicated to communicating with global institutional investors, including but not only from limited to Asia and Europe. By offering outstanding investor communication and maintain close contact with investors around the world, EuroEyes aims to bring its brand image to the next level, secure and expand its existing market shares.
Lowering Risks with Highly Flexible Strategy
Since economic recovery was expected to continue and significant challenges might remain moderate, EuroEyes will strengthen risk management capability during proactively expand its business. In line with the quality-oriented operation approach, the prevailing risks from external environment will be given due consideration to preserve healthy growth while ongoing expansionary plans are well-progressed.
